Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: A randomized trial

The SMART Study Group

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: A randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences